Perspective Therapeutics Announces Executive Financial Reorganization
PremiumCompany AnnouncementsPerspective Therapeutics Announces Executive Financial Reorganization
1M ago
Perspective Therapeutics price target lowered to $27 from $29 at RBC Capital
Premium
The Fly
Perspective Therapeutics price target lowered to $27 from $29 at RBC Capital
1M ago
Perspective Therapeutics price target lowered to $17 from $19 at Oppenheimer
Premium
The Fly
Perspective Therapeutics price target lowered to $17 from $19 at Oppenheimer
1M ago
Four new option listings on July 30th
PremiumThe FlyFour new option listings on July 30th
2M ago
Perspective Therapeutics to Participate at Upcoming Investor Conferences in August
Premium
Press Releases
Perspective Therapeutics to Participate at Upcoming Investor Conferences in August
2M ago
Perspective Therapeutics initiated with a Buy at BofA
Premium
The Fly
Perspective Therapeutics initiated with a Buy at BofA
2M ago
Perspective Therapeutics announces inclusion in the Russell 3000 Index
PremiumThe FlyPerspective Therapeutics announces inclusion in the Russell 3000 Index
3M ago
Perspective Therapeutics announces 1-for-10 reverse stock split
Premium
The Fly
Perspective Therapeutics announces 1-for-10 reverse stock split
3M ago
Perspective Therapeutics Announces 1-for-10 Reverse Stock Split
Premium
Press Releases
Perspective Therapeutics Announces 1-for-10 Reverse Stock Split
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100